Sense Biodetection Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

Sense Biodetection General Information

Description

Developer of user-centered diagnostic equipment designed to improve treatment and assist in decision-making in a decentralized healthcare system. The company's equipment includes point-of-care diagnostic tests that use molecular methods to a polymerase chain reaction (PCR) through fluid handling and temperature control, enabling clinics and medical professionals to detect infection and make treatment decisions immediately.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 29 and 30 The Quadrant
  • Abingdon Science Park
  • Abingdon OX14 3YS
  • England, United Kingdom
Primary Industry
Diagnostic Equipment
Parent Company
Vertical(s)
Corporate Office
  • 29 and 30 The Quadrant
  • Abingdon Science Park
  • Abingdon OX14 3YS
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sense Biodetection Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 01-Feb-2023 Completed Generating Revenue
8. Later Stage VC (Series B) 17-Nov-2021 Completed Generating Revenue
7. Later Stage VC (Series A) 29-Oct-2019 Completed Generating Revenue
6. Grant 23-Apr-2018 Completed Generating Revenue
5. Grant 01-Jan-2017 Completed Startup
4. Grant 01-Dec-2016 Completed Startup
3. Grant Completed Startup
2. Seed Round 08-Jun-2016 $738K $738K Completed Startup
1. Grant 01-May-2015 $257K Completed Startup
To view Sense Biodetection’s complete valuation and funding history, request access »

Sense Biodetection Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C2 Preferred
C1 Preferred
B2 Preferred Shares
B2 Preferred Shares
B1 Preferred Shares
A Ordinary 24,875 $0.001361 $16.2 $16.2 1x $16.2 4.96%
A Ordinary 19,153 $0.001361 $15.12 $15.12 1x $15.12 3.82%
To view Sense Biodetection’s complete cap table history, request access »

Sense Biodetection Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of user-centered diagnostic equipment designed to improve treatment and assist in decision-making in a decentr
Diagnostic Equipment
Abingdon, United Kingdom
24 As of 2025

Nehren, Germany
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sense Biodetection Competitors (23)

One of Sense Biodetection’s 23 competitors is Hain Lifescience, a Corporate Backed or Acquired company based in Nehren, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
New World Technologies Corporation New York, NY
Randox Laboratories Corporation Crumlin, United Kingdom
DiaSys Diagnostic Systems Corporate Backed or Acquired Holzheim, Germany
Agappe Diagnostics Formerly PE-Backed Ernakulam, India
You’re viewing 5 of 23 competitors. Get the full list »

Sense Biodetection Patents

Sense Biodetection Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D959693-S1 Diagnostic test device Active 31-Mar-2021
JP-2023539297-A Device Active 26-Aug-2020
JP-2023539299-A Device Pending 26-Aug-2020
JP-2026117208-A Device Pending 26-Aug-2020
JP-7902797-B2 Device Active 26-Aug-2020 B01L3/5023
To view Sense Biodetection’s complete patent history, request access »

Sense Biodetection Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sense Biodetection Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angels in Med City Angel Group Minority
Blueray Capital Lender/Debt Provider Minority
Cambridge Innovation Capital Venture Capital Minority
Department of Health of UK Corporation
Earlybird Venture Capital Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Sense Biodetection FAQs

  • When was Sense Biodetection founded?

    Sense Biodetection was founded in 2014.

  • Where is Sense Biodetection headquartered?

    Sense Biodetection is headquartered in Abingdon, United Kingdom.

  • What is the size of Sense Biodetection?

    Sense Biodetection has 24 total employees.

  • What industry is Sense Biodetection in?

    Sense Biodetection’s primary industry is Diagnostic Equipment.

  • Is Sense Biodetection a private or public company?

    Sense Biodetection is a Private company.

  • What is Sense Biodetection’s current revenue?

    The current revenue for Sense Biodetection is .

  • How much funding has Sense Biodetection raised over time?

    Sense Biodetection has raised $105M.

  • Who are Sense Biodetection’s investors?

    Angels in Med City, Blueray Capital, Cambridge Innovation Capital, Department of Health of UK, and Earlybird Venture Capital are 5 of 11 investors who have invested in Sense Biodetection.

  • Who are Sense Biodetection’s competitors?

    Hain Lifescience, New World Technologies, Randox Laboratories, DiaSys Diagnostic Systems, and Agappe Diagnostics are some of the 23 competitors of Sense Biodetection.

  • When was Sense Biodetection acquired?

    Sense Biodetection was acquired on 01-Feb-2023.

  • Who acquired Sense Biodetection?

    Sense Biodetection was acquired by Sherlock Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process